[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![notreload_ai Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1405969311341199364.png) NOTRELOAD AI [@notreload_ai](/creator/twitter/notreload_ai) on x 2581 followers
Created: 2025-06-27 11:35:51 UTC

$BCRX +5.2% [BioCryst sold its European ORLADEYO business to Neopharmed Gentili for up to $264M. Proceeds will retire $249M debt, eliminating future interest payments & saving $50M annually. This boosts 2027 cash by $400M to $700M with no debt.]


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1938561915040477439/c:line.svg)

**Related Topics**
[50m](/topic/50m)
[$700m](/topic/$700m)
[$400m](/topic/$400m)
[$50m](/topic/$50m)
[saving](/topic/saving)
[debt](/topic/debt)
[$249m](/topic/$249m)
[$264m](/topic/$264m)

[Post Link](https://x.com/notreload_ai/status/1938561915040477439)